Personal and professional factors associated with comprehensive ADR description of most recent past-month suspected ADR for 241 healthcare professionals who suspected ADR(s) in the previous month and provided a description, Uganda, 2013.

<p>* Covariates not fitted into the final logistic regression model.</p><p>Personal and professional factors associated with comprehensive ADR description of most recent past-month suspected ADR for 241 healthcare professionals who suspected ADR(s) in the previous month and provided a description, Uganda, 2013.</p

Survey-descriptions of 51 rare suspected Adverse Drug Reactions (ADRs) of Healthcare Professionals (HCPs) who suspected ADRs in the past 4 weeks.

<p><b>KEY:</b> ADR = ADVERSE DRUG REACTION; ART = ANTIRETROVIRAL THERAPY; AZT = ZIDOVUDINE; BNF = BRITISH NATIONAL FORMULARY; EFV = EFAVIRENZ; FLAGYL = METRONIDAZOLE; HAART = HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; ISS = IMMUNOSUPRESSED SYNDROME; IV = INTRAVENOUS; MEPHAQUINE = MEFLOQUINE; NVP = NEVIRAPINE; SEPTRIN = COTRIMOXAZOLE; SJS = STEVENS-JOHNSON SYNDROME; TDF = TENOFOVIR; 3TC = LAMIVUDINE;</p><p>* = CHECK APPENDIX S4 FOR TWO OR MORE DESCRIBED ADVERSE DRUG REACTIONS; PHARM = PHARMACIST/PHARMACY TECHNICIAN.</p><p>Survey-descriptions of 51 rare suspected Adverse Drug Reactions (ADRs) of Healthcare Professionals (HCPs) who suspected ADRs in the past 4 weeks.</p

Survey-description of the most recent past-month suspected ADR provided by 241 out of 268 HCPs who suspected ADRs in the previous month, Uganda, 2013.

<p>*Route of administration could be inferred for a further 63 (6 were by injection & 59 were oral) ADR descriptions.</p><p>Survey-description of the most recent past-month suspected ADR provided by 241 out of 268 HCPs who suspected ADRs in the previous month, Uganda, 2013.</p